Principles of biopharmaceutical protein formulation: an overview.
Sellers
Scott P
SP
ALZA Corporation, Mountain View, CA, USA.
Maa
Yuh-Fun
YF
D000327:Adsorption; D000818:Animals; D000975:Antioxidants; D001702:Biopharmaceutics; D002021:Buffers; D002152:Calorimetry, Differential Scanning; D002614:Chelating Agents; D002851:Chromatography, High Pressure Liquid; D004187:Disaccharides / Q000494:pharmacology; D005615:Freezing; D006801:Humans; D011309:Preservation, Biological; D011487:Protein Conformation; D011489:Protein Denaturation; D011506:Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D013501:Surface-Active Agents; D013696:Temperature
D000975:Antioxidants; D002021:Buffers; D002614:Chelating Agents; D004187:Disaccharides; D011506:Proteins; D013501:Surface-Active Agents